Cargando…

Expression profiling of receptor tyrosine kinases in high-grade neuroendocrine carcinoma of the lung: a comparative analysis with adenocarcinoma and squamous cell carcinoma

BACKGROUND: As the comprehensive genomic analysis of small cell lung cancer (SCLC) progresses, novel treatments for this disease need to be explored. With attention to the direct connection between the receptor tyrosine kinases (RTKs) of tumor cells and the pharmacological effects of specific inhibi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Matsumura, Yuki, Umemura, Shigeki, Ishii, Genichiro, Tsuta, Koji, Matsumoto, Shingo, Aokage, Keiju, Hishida, Tomoyuki, Yoshida, Junji, Ohe, Yuichiro, Suzuki, Hiroyuki, Ochiai, Atsushi, Goto, Koichi, Nagai, Kanji, Tsuchihara, Katsuya
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2015
Materias:	Original Article – Cancer Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4630254/ https://www.ncbi.nlm.nih.gov/pubmed/25989941 http://dx.doi.org/10.1007/s00432-015-1989-z

Ejemplares similares

Impact of Extratumoral Lymphatic Permeation on Postoperative Survival of Non–Small-Cell Lung Cancer Patients
por: Matsumura, Yuki, et al.
Publicado: (2014)

Immunophenotypic features of metastatic lymph node tumors to predict recurrence in N2 lung squamous cell carcinoma
por: Matsuwaki, Rie, et al.
Publicado: (2014)

Identification of Biological Properties of Intralymphatic Tumor Related to the Development of Lymph Node Metastasis in Lung Adenocarcinoma
por: Kirita, Keisuke, et al.
Publicado: (2013)

Therapeutic Priority of the PI3K/AKT/mTOR Pathway in Small Cell Lung Cancers as Revealed by a Comprehensive Genomic Analysis
por: Umemura, Shigeki, et al.
Publicado: (2014)

Podoplanin-expressing cancer-associated fibroblasts inhibit small cell lung cancer growth
por: Takahashi, Akiko, et al.
Publicado: (2015)

Stapling cartridge lavage cytology in limited resection for pulmonary malignant tumors: assessment of cytological status of the surgical margin
por: Miyoshi, Tomohiro, et al.
Publicado: (2019)

Signaling through the Phosphatidylinositol 3-Kinase (PI3K)/Mammalian Target of Rapamycin (mTOR) Axis Is Responsible for Aerobic Glycolysis mediated by Glucose Transporter in Epidermal Growth Factor Receptor (EGFR)-mutated Lung Adenocarcinoma
por: Makinoshima, Hideki, et al.
Publicado: (2015)

Successful treatment with nivolumab for SMARCA4‐deficient non‐small cell lung carcinoma with a high tumor mutation burden: A case report
por: Naito, Tomoyuki, et al.
Publicado: (2019)

Large pulmonary sclerosing pneumocytoma with massive necrosis and vascular invasion: a case report
por: Sakai, Takashi, et al.
Publicado: (2019)

Collagen type I induces EGFR‐TKI resistance in EGFR‐mutated cancer cells by mTOR activation through Akt‐independent pathway
por: Yamazaki, Shota, et al.
Publicado: (2018)

Changes in the tumor microenvironment during lymphatic metastasis of lung squamous cell carcinoma
por: Ikemura, Shinnosuke, et al.
Publicado: (2017)

Single cell time-lapse analysis reveals that podoplanin enhances cell survival and colony formation capacity of squamous cell carcinoma cells
por: Miyashita, Tomoyuki, et al.
Publicado: (2017)

The first case of SMARCB1 (INI1) - deficient squamous cell carcinoma of the pleura: a case report
por: Yoshida, Kazushi, et al.
Publicado: (2018)

CD200-positive cancer associated fibroblasts augment the sensitivity of Epidermal Growth Factor Receptor mutation-positive lung adenocarcinomas to EGFR Tyrosine kinase inhibitors
por: Ishibashi, Masayuki, et al.
Publicado: (2017)

Prognostic impact of count of extratumoral lymphatic permeation in lung adenocarcinoma and its relation to the immune microenvironment
por: Niimi, Takahiro, et al.
Publicado: (2022)

Metabolic Characterization of Antifolate Responsiveness and Non-responsiveness in Malignant Pleural Mesothelioma Cells
por: Sato, Yuzo, et al.
Publicado: (2018)

Retrospective analysis of the efficacy of chemotherapy and molecular targeted therapy for advanced pulmonary pleomorphic carcinoma
por: Tamura, Yosuke, et al.
Publicado: (2015)

Immunohistochemical analysis of SOX2 expression in small-cell neuroendocrine carcinoma of the endometrium
por: Ebisu, Yusuke, et al.
Publicado: (2020)

18F‐fluorodeoxyglucose uptake in PET is associated with the tumor microenvironment in metastatic lymph nodes and prognosis in N2 lung adenocarcinoma
por: Nomura, Kotaro, et al.
Publicado: (2022)

PTPRZ1 regulates calmodulin phosphorylation and tumor progression in small-cell lung carcinoma
por: Makinoshima, Hideki, et al.
Publicado: (2012)

Clinicopathological features and prognostic impact of dirty necrosis in metastatic lung cancers from the colon and rectum
por: Konishi, Yasuhito, et al.
Publicado: (2022)

Case report of aggressive treatments for large-cell neuroendocrine carcinoma of the esophagus
por: Nakao, Yosuke, et al.
Publicado: (2019)

Survival comparison between thymic carcinoma and thymic carcinoid: does it matter in clinical practice?
por: Hishida, Tomoyuki
Publicado: (2019)

Low-dose CT lung cancer screening in never-smokers and smokers: results of an eight-year observational study
por: Kakinuma, Ryutaro, et al.
Publicado: (2020)

Comprehensive biomarker analysis from phase II study of nivolumab in patients with thymic carcinoma
por: Katsuya, Yuki, et al.
Publicado: (2023)

Immunohistochemistry and oxygen saturation endoscopic imaging reveal hypoxia in submucosal invasive esophageal squamous cell carcinoma
por: Minakata, Nobuhisa, et al.
Publicado: (2023)

Prostatic Metastasis of Pulmonary Large Cell Neuroendocrine Carcinoma
por: Shimizu, Kumi, et al.
Publicado: (2012)

Prognostic impact of peripheral blood neutrophil to lymphocyte ratio in advanced-stage pulmonary large cell neuroendocrine carcinoma and its association with the immune-related tumour microenvironment
por: Shirasawa, Masayuki, et al.
Publicado: (2020)

Effect of a poly(ADP-ribose) polymerase-1 inhibitor against esophageal squamous cell carcinoma cell lines
por: Nasuno, Tomomitsu, et al.
Publicado: (2014)

Neuroendocrine Carcinoma of the Bladder
por: Kawahara, Takashi, et al.
Publicado: (2010)

Neuroendocrine Carcinoma of the Gallbladder
por: Vidal Panduro, Daniel A, et al.
Publicado: (2022)

Association of variations in HLA class II and other loci with susceptibility to EGFR-mutated lung adenocarcinoma
por: Shiraishi, Kouya, et al.
Publicado: (2016)

A secondary RET mutation in the activation loop conferring resistance to vandetanib
por: Nakaoku, Takashi, et al.
Publicado: (2018)

Study protocol for JCOG1807C (DEEP OCEAN): a interventional prospective trial to evaluate the efficacy and safety of durvalumab before and after operation or durvalumab as maintenance therapy after chemoradiotherapy against superior sulcus non-small cell lung cancer
por: Aokage, Keiju, et al.
Publicado: (2022)

Two cases of lung neuroendocrine carcinoma with carcinoid morphology
por: Inafuku, Kenji, et al.
Publicado: (2019)

Gallbladder neuroendocrine carcinoma: An important differential diagnosis of gallbladder adenocarcinoma
por: Ikezawa, Kenji, et al.
Publicado: (2021)

Mixed neuroendocrine carcinoma and hepatocellular carcinoma in the liver
por: Tanaka, Haruka, et al.
Publicado: (2022)

Procalcitonin expression in patients with large cell neuroendocrine carcinoma of the lung
por: Itoga, Masamichi, et al.
Publicado: (2021)

PARP inhibitor olaparib sensitizes esophageal carcinoma cells to fractionated proton irradiation
por: Kageyama, Shun-ichiro, et al.
Publicado: (2020)

Mixed Acinar-Neuroendocrine Carcinoma of the Pancreas with Neuroendocrine Predominance
por: Ogbonna, Onyekachi Henry, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_351t55s98vfmvug2bhcs7uqh1c